epigenomics ag (ECX:Xetra)
Thomas Taapken Ph.D.
Chief Executive Officer, Chief Financial Officer and Member of Executive Board, Epigenomics AG
|Age||Total Calculated Compensation||This person is connected to 21 board members in 2 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Thomas Taapken, Ph.D. has been the Chief Executive Officer of Epigenomics AG since April 1, 2013 and its Chief Financial Officer since April 1, 2011 and also serves as its Member of Management Board. Dr. Taapken served as the Chief Financial Officer at Elbion AG (alternate name elbion GmbH). He served as Chief Financial Officer of elbion NV since September 2005. He served as Chief Financial Officer at Biotie Therapies Corp. from September 2005 to March 31, 2011 and ...
Geneststrasse 5Phone: 49 30 243 450
Berlin, -- 10829
Fax: 49 30 2434 5555
Board Members Memberships*There is no Board Members Memberships data available.
Technische Universität Berlin
|There is no Competitor Compensation data available.|